These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21129127)

  • 41. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
    Chen H; Cantrell CR
    Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hepatitis A in Poland in 2003].
    Magdzik W
    Przegl Epidemiol; 2005; 59(2):289-95. PubMed ID: 16190532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The changing epidemiology of hepatitis A in Arizona following intensive immunization programs (1988-2007).
    Erhart LM; Ernst KC
    Vaccine; 2012 Sep; 30(42):6103-10. PubMed ID: 22835739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spanish Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JD; Ruiz Estremera A
    Med Clin (Barc); 1998 Sep; 111(9):341-6. PubMed ID: 9810537
    [No Abstract]   [Full Text] [Related]  

  • 47. Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995-2008.
    Tsou TP; Liu CC; Huang JJ; Tsai KJ; Chang HF
    Vaccine; 2011 Apr; 29(16):2956-61. PubMed ID: 21329774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute hepatitis A in Italy: incidence, risk factors and preventive measures.
    Tosti ME; Spada E; Romanò L; Zanetti A; Mele A;
    J Viral Hepat; 2008 Oct; 15 Suppl 2():26-32. PubMed ID: 18837830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hepatitis A in 1998].
    Sitarska-Gołebiowska J; Jończyk M
    Przegl Epidemiol; 2000; 54(1-2):143-50. PubMed ID: 11076156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis A in the era of vaccination.
    Wasley A; Fiore A; Bell BP
    Epidemiol Rev; 2006; 28():101-11. PubMed ID: 16775039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistent efficacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program.
    Zhuang FC; Qian W; Mao ZA; Gong YP; Jiang Q; Jiang LM; Chen NL; Chai SA; Mao JS
    Chin Med J (Engl); 2005 Nov; 118(22):1851-6. PubMed ID: 16313838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of a mass hepatitis A vaccination program in preadolescents.
    Domínguez A; Salleras L; Carmona G; Batalla J
    Vaccine; 2003 Jan; 21(7-8):698-701. PubMed ID: 12531343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis A: disease burden and current childhood vaccination strategies in the United States.
    Koslap-Petraco MB; Shub M; Judelsohn R
    J Pediatr Health Care; 2008; 22(1):3-11. PubMed ID: 18174084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of hepatitis A vaccination programs for migrant children on the incidence of hepatitis A in The Netherlands.
    Suijkerbuijk AW; Lindeboom R; van Steenbergen JE; Sonder GJ; Doorduyn Y
    Eur J Public Health; 2009 Jun; 19(3):240-4. PubMed ID: 19174503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Changes in seroepidemiology of hepatitis A virus infection in Catalonia in the period 1989-1996. Implications for new vaccination strategy].
    Bruguera M; Salleras L; Plans P; Vidal J; Navas E; Domínguez A; Batalla J; Taberner JL; Espuñes J
    Med Clin (Barc); 1999 Mar; 112(11):406-8. PubMed ID: 10231772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Control of hepatitis A by universal vaccination of children and adolescents: an achieved goal or a deferred appointment?
    Martinelli D; Bitetto I; Tafuri S; Lopalco PL; Mininni RM; Prato R
    Vaccine; 2010 Sep; 28(41):6783-8. PubMed ID: 20688041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil.
    Souto FJD; de Brito WI; Fontes CJF
    Vaccine; 2019 Feb; 37(6):771-775. PubMed ID: 30639462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis.
    Estripeaut D; Contreras R; Tinajeros O; Castrejón MM; Shafi F; Ortega-Barria E; DeAntonio R
    Vaccine; 2015 Jun; 33(28):3200-7. PubMed ID: 25981490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.